Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
Add more filters










Publication year range
1.
Cell ; 129(3): 579-91, 2007 May 04.
Article in English | MEDLINE | ID: mdl-17482550

ABSTRACT

The axonal shafts of neurons contain bundled microtubules, whereas extending growth cones contain unbundled microtubule filaments, suggesting that localized activation of microtubule-associated proteins (MAP) at the transition zone may bundle these filaments during axonal growth. Dephosphorylation is thought to lead to MAP activation, but specific molecular pathways have remained elusive. We find that Spinophilin, a Protein-phosphatase 1 (PP1) targeting protein, is responsible for the dephosphorylation of the MAP Doublecortin (Dcx) Ser 297 selectively at the "wrist" of growing axons, leading to activation. Loss of activity at the "wrist" is evident as an impaired microtubule cytoskeleton along the shaft. These findings suggest that spatially restricted adaptor-specific MAP reactivation through dephosphorylation is important in organization of the neuronal cytoskeleton.


Subject(s)
Axons/metabolism , Microfilament Proteins/metabolism , Microtubule-Associated Proteins/metabolism , Microtubules/metabolism , Nerve Tissue Proteins/metabolism , Neuropeptides/metabolism , Phosphoprotein Phosphatases/metabolism , Actins/metabolism , Animals , Cells, Cultured , Corpus Callosum/anatomy & histology , Cyclin-Dependent Kinase 5/metabolism , Doublecortin Domain Proteins , Doublecortin Protein , Hippocampus/metabolism , Humans , Magnetic Resonance Imaging , Male , Mice , Mice, Inbred Strains , Mice, Knockout , Microfilament Proteins/genetics , Microtubule-Associated Proteins/chemistry , Microtubule-Associated Proteins/genetics , Nerve Tissue Proteins/genetics , Neurites/metabolism , Neurons/metabolism , Neuropeptides/chemistry , Neuropeptides/genetics , Phosphorylation , Serine/metabolism
2.
J Cell Biol ; 165(5): 709-21, 2004 Jun 07.
Article in English | MEDLINE | ID: mdl-15173193

ABSTRACT

Humans with mutations in either DCX or LIS1 display nearly identical neuronal migration defects, known as lissencephaly. To define subcellular mechanisms, we have combined in vitro neuronal migration assays with retroviral transduction. Overexpression of wild-type Dcx or Lis1, but not patient-related mutant versions, increased migration rates. Dcx overexpression rescued the migration defect in Lis1+/- neurons. Lis1 localized predominantly to the centrosome, and after disruption of microtubules, redistributed to the perinuclear region. Dcx outlined microtubules extending from the perinuclear "cage" to the centrosome. Lis1+/- neurons displayed increased and more variable separation between the nucleus and the preceding centrosome during migration. Dynein inhibition resulted in similar defects in both nucleus-centrosome (N-C) coupling and neuronal migration. These N-C coupling defects were rescued by Dcx overexpression, and Dcx was found to complex with dynein. These data indicate Lis1 and Dcx function with dynein to mediate N-C coupling during migration, and suggest defects in this coupling may contribute to migration defects in lissencephaly.


Subject(s)
Cell Nucleus/metabolism , Centrosome/metabolism , Dyneins/metabolism , Microtubule-Associated Proteins/metabolism , Neurons/metabolism , Neuropeptides/metabolism , 1-Alkyl-2-acetylglycerophosphocholine Esterase , Animals , Brain/abnormalities , Brain/cytology , Brain/metabolism , Cell Differentiation/genetics , Cell Movement/genetics , Cell Nucleus/ultrastructure , Cells, Cultured , Centrosome/ultrastructure , Doublecortin Domain Proteins , Doublecortin Protein , Dyneins/genetics , Gene Expression Regulation, Developmental/genetics , Macromolecular Substances , Mice , Microtubule-Associated Proteins/genetics , Microtubules/genetics , Microtubules/metabolism , Microtubules/ultrastructure , Mutation/genetics , Nervous System Malformations/genetics , Nervous System Malformations/metabolism , Nervous System Malformations/physiopathology , Neurons/cytology , Neuropeptides/genetics , Up-Regulation/genetics
3.
Neuron ; 41(2): 215-27, 2004 Jan 22.
Article in English | MEDLINE | ID: mdl-14741103

ABSTRACT

Mutations in the doublecortin (DCX) gene in human or targeted disruption of the cdk5 gene in mouse lead to similar cortical lamination defects in the developing brain. Here we show that Dcx is phosphorylated by Cdk5. Dcx phosphorylation is developmentally regulated and corresponds to the timing of expression of p35, the major activating subunit for Cdk5. Mass spectrometry and Western blot analysis indicate phosphorylation at Dcx residue Ser297. Phosphorylation of Dcx lowers its affinity to microtubules in vitro, reduces its effect on polymerization, and displaces it from microtubules in cultured neurons. Mutation of Ser297 blocks the effect of Dcx on migration in a fashion similar to pharmacological inhibition of Cdk5 activity. These results suggest that Dcx phosphorylation by Cdk5 regulates its actions on migration through an effect on microtubules.


Subject(s)
Cyclin-Dependent Kinases/physiology , Microtubule-Associated Proteins/physiology , Neurons/physiology , Neuropeptides/physiology , Serine/physiology , Animals , Blotting, Western , Cell Movement/physiology , Cerebral Cortex/cytology , Cerebral Cortex/metabolism , Cyclin-Dependent Kinase 5 , Cyclin-Dependent Kinases/metabolism , Doublecortin Domain Proteins , Doublecortin Protein , Humans , Image Processing, Computer-Assisted , Immunoprecipitation , In Situ Hybridization , Mice , Mice, Knockout , Microtubule-Associated Proteins/metabolism , Microtubules/metabolism , Mutagenesis, Site-Directed , Nerve Tissue Proteins/physiology , Nervous System/growth & development , Neuropeptides/metabolism , Phenotype , Phosphorylation , Purines/pharmacology , Retroviridae/genetics , Roscovitine , Serine/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Transfection
4.
Infect Immun ; 66(8): 3519-22, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9673228

ABSTRACT

We have expressed the proline-rich antigen (PRA) from Coccidioides immitis in Escherichia coli and evaluated its potential as a vaccine candidate. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of the recombinant protein (rPRA) revealed two bands, which exhibited virtually identical primary amino acid sequences. T cells from rPRA-immunized BALB/c mice showed a significant in vitro proliferative response to rPRA. A small but statistically significant proliferative response was also induced by rPRA in T cells from mice immunized with whole-cell coccidioidal vaccines. BALB/c mice immunized with rPRA and challenged intraperitoneally with virulent C. immitis had a greatly reduced fungal burden in their lungs and spleens compared to unvaccinated mice. The number of organisms in the lungs was reduced 500-fold, and similar reductions were observed in the spleens of immunized mice. These studies support the continued development of rPRA as a candidate vaccine for prevention of coccidioidomycosis.


Subject(s)
Antigens, Fungal/immunology , Coccidioidomycosis/prevention & control , Fungal Vaccines/immunology , Glycoproteins/immunology , Vaccines, Synthetic/immunology , Animals , Antigens, Fungal/genetics , Cell Division , Cells, Cultured , Coccidioidomycosis/immunology , Coccidioidomycosis/microbiology , Disease Models, Animal , Drug Evaluation , Female , Fungal Proteins , Fungal Vaccines/genetics , Gene Expression , Glycoproteins/genetics , Mice , Mice, Inbred BALB C , Proline/immunology , T-Lymphocytes/immunology
6.
Infect Immun ; 66(2): 424-31, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9453590

ABSTRACT

The outcome of coccidioidomycosis depends to a large extent on the effectiveness of the T-cell-mediated immune (CMI) response to the fungal pathogen. For this reason, identification of Coccidioides immitis antigens which stimulate T cells is important for understanding the nature of host defense against the organism and essential for the development of an effective vaccine. Here we describe the immunogenicity of a 48-kDa T-cell-reactive protein (TCRP). The antigen is expressed by parasitic cells and localized in the cytoplasm. It stimulates the proliferative response and production of gamma interferon by T cells of mice immunized with C. immitis spherules. Specific antibody reactive with the recombinant TCRP (rTCRP) was detected in sera of patients with confirmed coccidioidal infection, and the highest titers of antibody to the recombinant protein correlated with elevated titers to the serodiagnostic complement fixation antigen of C. immitis. These results suggest that the TCRP is presented to the host during the course of infection. Immunization of BALB/c and C3H/HeN mice with the rTCRP affords a modest but significant level of protection against an intraperitoneal challenge with C. immitis. It is suggested that the rTCRP may be able to contribute to a multicomponent vaccine designed to stimulate CMI response against the parasitic cycle of C. immitis.


Subject(s)
Coccidioides/immunology , Fungal Proteins/immunology , Fungal Vaccines/immunology , T-Lymphocytes/immunology , Vaccines, Synthetic/immunology , Amino Acid Sequence , Animals , Female , Guinea Pigs , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Molecular Sequence Data , Molecular Weight , Vaccination
7.
Am J Surg ; 169(5): 471-5, 1995 May.
Article in English | MEDLINE | ID: mdl-7747821

ABSTRACT

BACKGROUND: The frequency and causes of gastrointestinal complications following esophagectomy for malignancy are unknown. PATIENTS AND METHODS: We reviewed 295 esophagectomies performed for malignancy between January 1980 and September 1994 in order to determine the frequency and causes of early and late gastrointestinal complications. RESULTS: Compared to transhiatal and left thoracoabdominal esophagectomies, esophagectomies carried out through a right posterolateral thoracotomy with cervical esophagogastric anastomosis had a higher incidence of delayed gastric emptying (11%), pneumonia (26%), and hospital death (9%). The same operation had a higher incidence of gastroesophageal reflux (20%) and dysphagia requiring esophageal dilatation (53%). We found no independent effect of gastric drainage procedures, feeding jejunostomy, preoperative radiotherapy, pathology, or age on these outcomes. Women had no operative mortality, but a higher incidence of gastroesophageal reflux and diarrhea following esophagectomy. CONCLUSIONS: Surgical techniques aimed at improving gastric emptying following esophagectomy for cancer should improve operative morbidity and mortality.


Subject(s)
Adenocarcinoma/surgery , Carcinoma, Squamous Cell/surgery , Deglutition Disorders/etiology , Esophageal Neoplasms/surgery , Esophagectomy/adverse effects , Gastroesophageal Reflux/etiology , Pneumonia/etiology , Stomach Neoplasms/surgery , Adenocarcinoma/mortality , Adenocarcinoma/physiopathology , Adolescent , Adult , Aged , Aged, 80 and over , Anastomosis, Surgical/adverse effects , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/physiopathology , Cardia , Deglutition Disorders/epidemiology , Drainage , Esophageal Neoplasms/mortality , Esophageal Neoplasms/physiopathology , Esophagectomy/methods , Esophagus/surgery , Female , Follow-Up Studies , Gastric Emptying , Gastroesophageal Reflux/mortality , Gastroesophageal Reflux/physiopathology , Hospital Mortality , Humans , Incidence , Jejunostomy , Male , Middle Aged , Pneumonia/epidemiology , Reoperation , Stomach Neoplasms/mortality , Stomach Neoplasms/physiopathology , Survival Rate
8.
J Biol Chem ; 268(33): 24818-23, 1993 Nov 25.
Article in English | MEDLINE | ID: mdl-7693705

ABSTRACT

The cell surface protein CD14 binds bacterial lipopolysaccharide (LPS) in the presence of the serum protein, LPS-binding protein (LBP). This interaction is important for LPS-induced activation of mammalian myeloid cells. We performed quantitative studies of 3H-labeled LPS binding to human CD14 expressed on Chinese hamster ovary cells and on a human macrophage cell line (THP-1). At the concentrations studied (20-100 nM) LPS binding required the expression of CD14 and could be inhibited by a subset of anti-CD14 monoclonal antibodies. LBP was required for LPS binding to CD14. The binding occurred within 10 min and was relatively unaffected by temperature over the range of 4-37 degrees C. Quantitative binding assays were performed at 10 degrees C, or at 37 degrees C, using Chinese hamster ovary cells depleted of ATP. In both cases, 75-90% of the LPS could be released by treatment with phosphatidylinositol-specific phospholipase C, suggesting that it remains associated with the glycosyl phosphatidylinositol-anchored CD14. The apparent dissociation constant of recombinant human CD14 expressed on Chinese hamster ovary cells for LPS at 10 degrees C was 2.74 (+/- 0.99) x 10(-8) M; the apparent dissociation constant of CD14 expressed on THP-1 cells at 10 degrees C was 4.89 (+/- 1.42) x 10(-8) M. In both cell lines, at saturating LPS concentrations, the molar ratio of LPS bound per surface CD14 was approximately 20:1. At 37 degrees C the apparent dissociation constant of recombinant human CD14 for LPS at 37 degrees C was 2.7 (+/- 1.2) x 10(-8) M, and the molar ratio of LPS bound per surface CD14 was approximately 8:1. Although the difference in molar ratio of LPS bound per surface CD14 at the two temperatures is difficult to interpret, it is clear that at both temperatures the molar ratio is not 1:1. The basis of this phenomenon is unclear, but may involve the repeated leucine-rich motifs, which are found within CD14.


Subject(s)
Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Lipopolysaccharides/metabolism , Animals , Antibodies, Monoclonal , Antigens, CD/immunology , Antigens, Differentiation, Myelomonocytic/immunology , CHO Cells , Cell Line , Cricetinae , Humans , Lipopolysaccharide Receptors , Macrophages/metabolism , Mice , Mice, Inbred BALB C , Protein Binding
9.
Antimicrob Agents Chemother ; 34(1): 13-6, 1990 Jan.
Article in English | MEDLINE | ID: mdl-2327748

ABSTRACT

We infected mice with arthroconidia of Coccidioides immitis by intraperitoneal injection and 48 h later treated them with either oral fluconazole or SDZ89-485, a new triazole. Both drugs completely inhibited fungal growth when administered at a dose of 50 mg/kg of body weight twice a day, but only SDZ89-485 was fully inhibitory at a dose of 5 mg/kg twice a day. In a second experiment, treatment with SDZ89-485 was delayed until 8 days after infection to allow infection to be well established before treatment. Both 5 and 50 mg/kg twice a day were effective regimens, which establishes that SDZ89-485 has activity against spherules in vivo. Mice that received fluconazole (50 mg/kg twice a day) had a peak level in blood of 60 micrograms/ml 1 h after a dose, but no measurable amount was found after 12 h. SDZ89-485 was more slowly absorbed, reaching a peak level in blood of 14 micrograms/ml at 12 to 15 h after a dose of 50 mg/kg. We conclude that SDZ89-485 is more effective than fluconazole as treatment for experimental systemic coccidioidomycosis in mice, even though fluconazole achieves higher peak levels in blood.


Subject(s)
Antifungal Agents/therapeutic use , Coccidioidomycosis/drug therapy , Fluconazole/therapeutic use , Triazoles/therapeutic use , Animals , Antifungal Agents/pharmacokinetics , Coccidioides , Coccidioidomycosis/microbiology , Female , Fluconazole/pharmacokinetics , Mice , Mice, Inbred BALB C , Mice, Inbred DBA , Triazoles/pharmacokinetics
10.
J Infect Dis ; 140(4): 581-9, 1979 Oct.
Article in English | MEDLINE | ID: mdl-229175

ABSTRACT

When genetically serum-resistant Escherichia coli, Klebsiella pneumoniae, and Citrobacter freundii, but not Pseudomonas aeruginosa or Proteus mirabilis, were exposed to polymyxin B, they became susceptible to the bactericidal action of normal human and rabbit sera. In constrast, beta-lactam and aminoglycoside antibiotics did not render any serum-resistant bacteria serum-sensitive. Synergy between polymyxin B and the serum bactericidal system could be demonstrated by the addition of polymyxin B to bacteria in vitro, as well as to bacilli in serum from rabbits injected with the antibiotic. Polymyxin B-treated bacteria were killed by normal, lysozyme-depleted, C2-deficient, and hypogammaglobulinemic sera, but not by heated or C6-deficient sera. These findings indicate that polymyxin B-treated bacteria can be killed via the alternative complement pathway. However, C3 and C3b were detected on the surface of serum-resistant E. coli, regardless of whether the bacteria had been treated with polymyxin B. This observation suggests that a change in susceptibility to the alternative complement pathway was not the only explanation for the acquired serum sensitivity. Polymyxin B may also affect a step in the complement sequence beyond the activation of C3, a step that is apparently blocked in serum-resistant gram-negative bacteria.


Subject(s)
Blood Bactericidal Activity , Complement System Proteins/immunology , Enterobacteriaceae/drug effects , Muramidase/immunology , Polymyxin B/pharmacology , Polymyxins/pharmacology , Animals , Anti-Bacterial Agents/pharmacology , Citrobacter/drug effects , Citrobacter/immunology , Complement Activation , Complement C3/immunology , Complement C3b/immunology , Complement Pathway, Alternative , Escherichia coli/drug effects , Escherichia coli/immunology , Humans , In Vitro Techniques , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/immunology , Rabbits
11.
J Clin Invest ; 63(5): 912-921, 1979 May.
Article in English | MEDLINE | ID: mdl-376551

ABSTRACT

The serum bactericidal activity (SBA) of cirrhotic patients was compared with that of normal individuals using the release of (51)Cr from radiolabeled Escherichia coli as the assay method. 80% (22/27) of patients were found to have deficient SBA against at least one of three smooth, serum-sensitive test strains of E. coli. Cirrhotic patients were found to have normal levels of serum lysozyme. Although some patients were mildly hypocomplementemic, this abnormality did not correlate with the presence of a bactericidal defect. Bactericidal antibody in normal and cirrhotics' sera was limited to the immunoglobulin (Ig)M class. Purified IgM from patients with deficient SBA against E. coli 0111 had lower concentrations of bactericidal antibody for that E. coli than did IgM from normal sera; the calculated bactericidal activity of total serum IgM was also lower. The bactericidal defect in cirrhotic serum could be completely corrected by either human antiserum to the homologous strain of E. coli or by purified, normal human IgM. However, because higher concentrations of IgM were required to restore normal SBA to a cirrhotic's serum than to agammaglobulinemic serum, there may be an inhibitor of bactericidal antibody in addition to a deficiency of bactericidal IgM antibody to E. coli in the serum of patients with cirrhosis. The bactericidal activity of the alternative complement pathway was also assessed. Sera from cirrhotic patients had no deficit in SBA attributable to the alternative complement pathway. In fact, in some, the activity of the alternative complement pathway was supernormal, compensating in part for the deficit in IgM-mediated SBA.


Subject(s)
Blood Bactericidal Activity , Escherichia coli , Liver Cirrhosis/blood , Antibodies, Bacterial/analysis , Chromium Radioisotopes , Complement C3/analysis , Complement C4/analysis , Complement Factor B/analysis , Escherichia coli/immunology , Escherichia coli/metabolism , Humans , Immunoglobulin G/analysis , Immunoglobulin M/analysis , Liver Cirrhosis/enzymology , Liver Cirrhosis/immunology , Muramidase/blood
15.
Arch Phys Med Rehabil ; 51(7): 423-6, 1970 Jul.
Article in English | MEDLINE | ID: mdl-5433607
SELECTION OF CITATIONS
SEARCH DETAIL
...